DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia

NCT00003840 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: DTGM fusion protein

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]